title: Synchronous tumor with diffuse large B-cell lymphoma and ameboma.
authors.affiliation: Sumitomo Hospital, Osaka, Japan.
authors.forename: Mari
authors.initials: M
authors.lastname: Takashima
authors.forename: Tsunayuki
authors.initials: T
authors.lastname: Kakimoto
authors.forename: Hideaki
authors.initials: H
authors.lastname: Saito
authors.forename: Sayaka
authors.initials: S
authors.lastname: Misaki
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Onishi
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Kasugai
authors.forename: Keigo
authors.initials: K
authors.lastname: Akuta
authors.forename: Hidenori
authors.initials: H
authors.lastname: Kasahara
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Doi
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Ujiie
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Sugahara
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Hoshida
authors.forename: Hiroto
authors.initials: H
authors.lastname: Sakoda
mesh_terms: D015746:Abdominal Pain / Q000469:parasitology; D000368:Aged; D000563:Amebicides / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000953:Antigens, Protozoan / Q000302:isolation & purification; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology; D003113:Colonoscopy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004748:Entamoeba histolytica / Q000276:immunology / Q000302:isolation & purification*; D004749:Entamoebiasis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005334:Fever / Q000469:parasitology; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000008:administration & dosage; D015431:Weight Loss
chemical_list: D000563:Amebicides; D058846:Antibodies, Monoclonal, Murine-Derived; D000953:Antigens, Protozoan; D000970:Antineoplastic Agents; D008795:Metronidazole; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone